All people with Type 1 and some with Type 2 diabetes need the drug, but the price of versions of the drug nearly tripled from 2002 to 2013, according to one study. Dr. Steffie Woolhandler, a study author and professor at the City University of New York’s Hunter College, said the escalating cost of a century-old drug, albeit with new formulations, is jeopardizing the health of too many Americans. Under the sweeping climate and health bill called the Inflation Reduction Act, more than 3 million Medicare recipients who take insulin will get some financial relief. Beginning next year, Medicare recipients will see insulin prices capped at $35 a month under the federal law. That cap will not extend to younger Americans who are more likely to ration insulin. Visit the link in our bio for more information.